Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02864992
Title Tepotinib Phase II in Non-small Cell Lung Cancer (NSCLC) Harboring MET Alterations (VISION)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors EMD Serono Research & Development Institute, Inc.
Indications

lung adenocarcinoma

Therapies

Tepotinib

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU | BEL | AUT

Additional content available in CKB BOOST